Gordon Bruton
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gordon Bruton.
Chemical Communications | 2002
Nigel A. Swain; Richard C. D. Brown; Gordon Bruton
The ring openings of 1-acetyl-4-phenyl-3-oxabicyclo[3.1.0]hexane afforded alpha-acetyl-gamma-butyrolactone that underwent a novel diazo-transfer reaction, followed by C-H insertion, to provide a series of endo,exo-furofuranone analogues.
ChemMedChem | 2018
David Bowkett; R. Talon; Cynthia Tallant; Christopher J. Schofield; Frank von Delft; Stefan Knapp; Gordon Bruton; Paul E. Brennan
Epigenetics is a rapidly growing field in drug discovery. Of particular interest is the role of post‐translational modifications to histones and the proteins that read, write, and erase such modifications. The development of inhibitors for reader domains has focused on single domains. One of the major difficulties of designing inhibitors for reader domains is that, with the notable exception of bromodomains, they tend not to possess a well‐enclosed binding site amenable to small‐molecule inhibition. As many of the proteins in epigenetic regulation have multiple domains, there are opportunities for designing inhibitors that bind at a domain–domain interface which provide a more suitable interaction pocket. Examination of X‐ray structures of multiple domains involved in recognising and modifying post‐translational histone marks using the SiteMap algorithm identified potential binding sites at domain–domain interfaces. For the tandem plant homeodomain–bromodomain of SP100C, a potential inter‐domain site identified computationally was validated experimentally by the discovery of ligands by X‐ray crystallographic fragment screening.
Biochemical Pharmacology | 2007
Andrew D. Medhurst; Michael A. Briggs; Gordon Bruton; Andrew R. Calver; Iain P. Chessell; Barry Crook; John B. Davis; Robert P. Davis; Andrew G. Foley; Teresa Heslop; Warren D. Hirst; Stephen J. Medhurst; Sandrine Ociepka; Alison M. Ray; Ciaran M. Regan; Becky Sargent; Joanne Schogger; Tania O. Stean; Brenda K. Trail; Neil Upton; Trevor White; Barry Sidney Orlek; David M. Wilson
Journal of Organic Chemistry | 2001
Richard C. D. Brown; Carole J. R. Bataille; Gordon Bruton; Jeremy David Hinks; Nigel A. Swain
Archive | 2003
Desmond John Best; Gordon Bruton; Thomas Daniel Heightman; Barry Sidney Orlek
Journal of Organic Chemistry | 2004
Nigel A. Swain; Richard C. D. Brown; Gordon Bruton
European Journal of Medicinal Chemistry | 2003
Gordon Bruton; Anthony Huxley; Peter J. O'Hanlon; Barry Sidney Orlek; Drake Eggleston; John Humphries; Simon A. Readshaw; Andrew West; Stephen Ashman; Murray J.B. Brown; Keith Moore; Andrew J. Pope; Karen O'Dwyer; Lei Wang
Archive | 2000
Gordon Bruton; Andrew SmithKline Beecham Pharmac. Faller; Barry Sidney mithKline Beecham Pharmac. Orlek; Kishore Kalidas Rana; Graham Walker
Archive | 2008
Gordon Bruton; Barry Sidney Orlek; Geoffrey Stemp
Archive | 2004
Gordon Bruton; Barry Sidney Orlek; Kishore Kalidas Rana